You have 9 free searches left this month | for more free features.

NKT cells

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Neuroblastoma
  • GINAKIT Cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Jan 18, 2023

Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston

Recruiting
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • +4 more
  • CD19.CAR-aNKT cells
  • +2 more
  • Houston, Texas
  • +1 more
Aug 19, 2022

IBD, Primary Sclerosing Cholangitis Trial in Lille (collection of gut biopsies collection of blood samples)

Completed
  • Inflammatory Bowel Diseases
  • Primary Sclerosing Cholangitis
  • collection of gut biopsies collection of blood samples
  • Lille, France
    CHRU, Hôpital Claude Huriez
Aug 26, 2020

NSCLC, Gastric Cancer, Hepatocellular Carcinoma Trial in Beijing, Shanghai (natural killer T cell)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • natural killer T cell
  • Beijing, China
  • +1 more
Apr 26, 2022

Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

Recruiting
  • Pancreatic Cancer
  • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
  • Shanghai, China
    Changhai Hospital affiliated to Naval Medical University
Mar 13, 2023

Olive Leaf Tea Against COVID-19

Completed
  • Immunomodulation
  • Olive Leaf Tea
  • Konya, Selcuklu, Turkey
    Tumosan Konya Tractor Factory
Feb 1, 2022

Cellular Immunity and Renal Cell Cancer

Completed
  • NK Cell Mediated Immunity
  • +2 more
    • Rijeka, Croatia
      Clinical Hospital Center Rijeka
    Sep 19, 2021

    NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

    Not yet recruiting
    • NHL, Relapsed, Adult
    • +3 more
    • KUR-502
    • (no location specified)
    Aug 2, 2022

    Progression to Myeloma in Asymptomatic Monoclonal Gammopathies

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Plasma Cell Myeloma
    • Biospecimen Collection
    • Laboratory Biomarker Analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 4, 2021

    Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)

    Recruiting
    • Smoldering Plasma Cell Myeloma
    • Biopsy Specimen Radiography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 12, 2021

    NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +5 more
    • Infusion of iNKT cells and CD8+T cells
    • Shanghai, Shanghai, China
      Shanghai Public Health Clinical Center
    May 6, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • inulin
    • +2 more
    • Candiolo, Turin, Italy
      Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
    Apr 7, 2023

    Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis

    Not yet recruiting
    • Rheumatoid Arthritis
      • (no location specified)
      Oct 4, 2022

      Mucosal-Associated Invariant T Cells in Cases of Miscarriage

      Recruiting
      • Miscarriage
      • MAIT cells
      • Assiut, Cairo, Egypt
        Ahmed Abbas
      Aug 12, 2021

      Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)

      Completed
      • Malignant Solid Tumor
      • Infusion of iNKT cells
      • Shanghai, China
        Shanghai Public Health Clinical Center, Fudan University
      May 6, 2022

      Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))

      Recruiting
      • Malignant Sarcoma
      • Natural Killer (NK) cells (a new immunotherapy)
      • Madrid, Spain
        Hospital Universitario La Paz
      Jul 19, 2023

      Cancer Trial in Genova (Short-term modified fasting)

      Recruiting
      • Cancer
      • Short-term modified fasting
      • Genova, Italy
        San Martino Hospital
      Feb 17, 2023

      Paravertebral Block, Pectoralis and Serratus Plane Nerve Blocks, Breast Cancer Trial (procedure, device, drug)

      Not yet recruiting
      • Paravertebral Block
      • +4 more
      • Paravertebral nerve block (PVB)
      • +5 more
      • (no location specified)
      Apr 3, 2023

      Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

      Recruiting
      • Gastric Cancer
      • sintilimab+metronomic PLOF
      • Shanghai, China
        Huashan Hospital, Fudan University
      Sep 22, 2023

      Allergic Rhinitis Due to Grass Pollen Trial in Lublin (Ismigen, Placebo)

      Completed
      • Allergic Rhinitis Due to Grass Pollen
      • Lublin, Poland
        Department of Pulmonary Diseases and Children Rheumatology, Medi
      Apr 2, 2022

      Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor

      Completed
      • Ovarian Cancer
      • +3 more
      • Assessment of percentage of Treg, Th17, NKT and serum level of HE4, CA125 and ROMA.
      • Lublin, Poland
        IInd Department of Gynecology
      Dec 17, 2018

      Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

      Recruiting
      • Advanced Hepatocellular Carcinoma
      • Bifidobacterium Bifidum Oral Product
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Sun Yat-Sen University
      Nov 16, 2022

      Immune System of End Stage Kidney Disease on Dialysis and Kidney

      Recruiting
      • End Stage Kidney Disease
      • +3 more
      • SARS - COV 2 VACCINE
      • Ioannina, Epirus, Greece
        Evangelia Ntounousi
      Sep 28, 2021

      Obesity Adult Onset Trial in Chapel Hill (SPM Active)

      Completed
      • Obesity Adult Onset
      • SPM Active
      • Chapel Hill, North Carolina
        UNC Chapel Hill Family Medicine Center
      Jun 14, 2022

      Platelet and Immune Response in Covid-19 Vaccine

      Recruiting
      • SARS-CoV-2 Vaccination
        • Roma, Italy
          Sapienza University of Rome
        Dec 27, 2021